Fulcrum Therapeutics Inc. (FULC) Misses Q1 EPS by 2c

Fulcrum Therapeutics Inc. (NASDAQ: FULC) reported Q1 EPS of ($0.28), $0.02 worse than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Fulcrum Therapeutics Inc. (FULC) click here.

You May Also Be Interested In

• Abercrombie & Fitch (ANF) Tops Q2 EPS by $2.19, Offers Guidance
• LightInTheBox Holding (LITB) Reports Q2 EPS of $0.01
• Li Auto Inc. (LI) Misses Q2 EPS by 2c; misses on guidance